mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.4 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.4 |
mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.4 |